$CBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST BIOSCIENCES, INC.. Get notifications about new insider transactions in CATALYST BIOSCIENCES, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 16.01 | 950 | 15,214 | 23,755 | 24.7 K to 23.8 K (-3.85 %) |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 950 | 1,663 | 24,705 | 23.8 K to 24.7 K (+4.00 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 851 | 1,489 | 124,403 | |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 11,149 | 19,511 | 125,254 | |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 15.00 | 851 | 12,765 | 46,917 | 47.8 K to 46.9 K (-1.78 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 851 | 1,489 | 47,768 | 46.9 K to 47.8 K (+1.81 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 15.02 | 11,149 | 167,474 | 46,917 | 58.1 K to 46.9 K (-19.20 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 11,149 | 19,511 | 58,066 | 46.9 K to 58.1 K (+23.76 %) |
Sep 18 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 11,000 | 19,250 | 6,782 | |
Sep 18 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 17.19 | 11,000 | 189,101 | 23,755 | 34.8 K to 23.8 K (-31.65 %) |
Sep 18 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 11,000 | 19,250 | 34,755 | 23.8 K to 34.8 K (+46.31 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 8,000 | 14,000 | 13,000 | |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 15.07 | 8,000 | 120,528 | 2,799 | 10.8 K to 2.8 K (-74.08 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 8,000 | 14,000 | 10,799 | 2.8 K to 10.8 K (+285.82 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 10,000 | 17,500 | 34,000 | |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 15.02 | 10,000 | 150,191 | 23,755 | 33.8 K to 23.8 K (-29.63 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 10,000 | 17,500 | 33,755 | 23.8 K to 33.8 K (+42.10 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 2,100 | 3,675 | 0 | |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 15.07 | 2,100 | 31,644 | 7,735 | 9.8 K to 7.7 K (-21.35 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 2,100 | 3,675 | 9,835 | 7.7 K to 9.8 K (+27.15 %) |
Sep 02 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 13,955 | 24,421 | 2,100 | |
Sep 02 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 14.54 | 13,955 | 202,881 | 7,735 | 21.7 K to 7.7 K (-64.34 %) |
Sep 02 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 13,955 | 24,421 | 21,690 | 7.7 K to 21.7 K (+180.41 %) |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 9,400 | 16,450 | 136,403 | |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 600 | 1,050 | 145,803 | |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 14.54 | 9,400 | 136,645 | 46,917 | 56.3 K to 46.9 K (-16.69 %) |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 9,400 | 16,450 | 56,317 | 46.9 K to 56.3 K (+20.04 %) |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 14.50 | 600 | 8,700 | 46,917 | 47.5 K to 46.9 K (-1.26 %) |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 600 | 1,050 | 47,517 | 46.9 K to 47.5 K (+1.28 %) |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 5,400 | 9,450 | 21,000 | |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 600 | 1,050 | 26,400 | |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 14.50 | 5,400 | 78,300 | 2,799 | 8.2 K to 2.8 K (-65.86 %) |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 5,400 | 9,450 | 8,199 | 2.8 K to 8.2 K (+192.93 %) |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 14.50 | 600 | 8,700 | 2,799 | 3.4 K to 2.8 K (-17.65 %) |
Sep 01 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 600 | 1,050 | 3,399 | 2.8 K to 3.4 K (+21.44 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 7,900 | 13,825 | 44,000 | |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 2,100 | 3,675 | 51,900 | |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 14.04 | 7,900 | 110,903 | 23,755 | 31.7 K to 23.8 K (-24.96 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 7,900 | 13,825 | 31,655 | 23.8 K to 31.7 K (+33.26 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 14.00 | 2,100 | 29,400 | 23,755 | 25.9 K to 23.8 K (-8.12 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 2,100 | 3,675 | 25,855 | 23.8 K to 25.9 K (+8.84 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 4,900 | 8,575 | 17,055 | |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 500 | 875 | 0 | |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 1,600 | 2,800 | 500 | |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 14.50 | 4,900 | 71,074 | 7,735 | 12.6 K to 7.7 K (-38.78 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 4,900 | 8,575 | 12,635 | 7.7 K to 12.6 K (+63.35 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 14.08 | 500 | 7,040 | 7,735 | 8.2 K to 7.7 K (-6.07 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 500 | 875 | 8,235 | 7.7 K to 8.2 K (+6.46 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 14.00 | 1,600 | 22,406 | 7,735 | 9.3 K to 7.7 K (-17.14 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 1,600 | 2,800 | 9,335 | 7.7 K to 9.3 K (+20.69 %) |
Aug 26 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 2,400 | 4,200 | 146,403 | |
Aug 26 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 13.52 | 2,400 | 32,441 | 46,917 | 49.3 K to 46.9 K (-4.87 %) |
Aug 26 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 2,400 | 4,200 | 49,317 | 46.9 K to 49.3 K (+5.12 %) |
Aug 17 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 4,600 | 8,050 | 148,803 | |
Aug 17 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 13.51 | 4,600 | 62,134 | 46,917 | 51.5 K to 46.9 K (-8.93 %) |
Aug 17 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 4,600 | 8,050 | 51,517 | 46.9 K to 51.5 K (+9.80 %) |
Aug 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 4,500 | 7,875 | 29,500 | |
Aug 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 13.51 | 4,500 | 60,781 | 2,799 | 7.3 K to 2.8 K (-61.65 %) |
Aug 17 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 4,500 | 7,875 | 7,299 | 2.8 K to 7.3 K (+160.77 %) |
Aug 26 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 2,500 | 4,375 | 27,000 | |
Aug 26 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 13.55 | 2,500 | 33,863 | 2,799 | 5.3 K to 2.8 K (-47.18 %) |
Aug 26 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 2,500 | 4,375 | 5,299 | 2.8 K to 5.3 K (+89.32 %) |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | M | 1.75 | 15,000 | 26,250 | 15,000 | |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Sell | S | 12.63 | 15,000 | 189,384 | 0 | 15 K to 0 (-100.00 %) |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Buy | M | 1.75 | 15,000 | 26,250 | 15,000 | 0 to 15 K |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 2.93 | 4,595 | 13,463 | 37,905 | |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 1,135 | 1,986 | 2,100 | |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 1,050 | 1,838 | 2,100 | |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 12.69 | 6,780 | 86,023 | 7,735 | 14.5 K to 7.7 K (-46.71 %) |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 2.93 | 4,595 | 13,463 | 14,515 | 9.9 K to 14.5 K (+46.32 %) |
Aug 12 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 2,185 | 3,824 | 9,920 | 7.7 K to 9.9 K (+28.25 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 5,700 | 9,975 | 153,403 | |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 12.04 | 2,850 | 34,304 | 46,917 | 49.8 K to 46.9 K (-5.73 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 12.02 | 2,850 | 34,251 | 49,767 | 52.6 K to 49.8 K (-5.42 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 5,700 | 9,975 | 52,617 | 46.9 K to 52.6 K (+12.15 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 771 | 1,349 | 3,150 | |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 12.04 | 200 | 2,407 | 7,735 | 7.9 K to 7.7 K (-2.52 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 12.02 | 200 | 2,404 | 7,935 | 8.1 K to 7.9 K (-2.46 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 12.00 | 371 | 4,452 | 8,135 | 8.5 K to 8.1 K (-4.36 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 771 | 1,349 | 8,506 | 7.7 K to 8.5 K (+9.97 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 5,700 | 9,975 | 34,000 | |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 12.04 | 2,850 | 34,304 | 2,799 | 5.6 K to 2.8 K (-50.45 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 12.02 | 2,850 | 34,251 | 5,649 | 8.5 K to 5.6 K (-33.53 %) |
Aug 11 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 5,700 | 9,975 | 8,499 | 2.8 K to 8.5 K (+203.64 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 636 | 1,113 | 3,921 | |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Option Exercise | M | 1.75 | 693 | 1,213 | 4,557 | |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 12.00 | 636 | 7,632 | 7,735 | 8.4 K to 7.7 K (-7.60 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 636 | 1,113 | 8,371 | 7.7 K to 8.4 K (+8.22 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Sell | S | 12.00 | 693 | 8,316 | 7,735 | 8.4 K to 7.7 K (-8.22 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | VP - Drug Discovery ... | Buy | M | 1.75 | 693 | 1,213 | 8,428 | 7.7 K to 8.4 K (+8.96 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 5.10 | 6,451 | 32,900 | 16,049 | |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 1.75 | 5,562 | 9,734 | 22,252 | |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 1.75 | 4,200 | 7,350 | 0 | |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 1.75 | 25,000 | 43,750 | 15,975 | |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 10.39 | 41,213 | 428,133 | 7,735 | 48.9 K to 7.7 K (-84.20 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 5.10 | 6,451 | 32,900 | 48,948 | 42.5 K to 48.9 K (+15.18 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 1.75 | 5,562 | 9,734 | 42,497 | 36.9 K to 42.5 K (+15.06 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 1.75 | 4,200 | 7,350 | 36,935 | 32.7 K to 36.9 K (+12.83 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 1.75 | 25,000 | 43,750 | 32,735 | 7.7 K to 32.7 K (+323.21 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 5,700 | 9,975 | 159,103 | |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 12.00 | 1,300 | 15,601 | 46,917 | 48.2 K to 46.9 K (-2.70 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 11.05 | 4,400 | 48,617 | 48,217 | 52.6 K to 48.2 K (-8.36 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 5,700 | 9,975 | 52,617 | 46.9 K to 52.6 K (+12.15 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 5,263 | 9,210 | 39,700 | |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 12.00 | 1,300 | 15,601 | 2,799 | 4.1 K to 2.8 K (-31.72 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 11.05 | 3,963 | 43,803 | 4,099 | 8.1 K to 4.1 K (-49.16 %) |
Jul 31 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 5,263 | 9,210 | 8,062 | 2.8 K to 8.1 K (+188.03 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | M | 1.75 | 3,037 | 5,315 | 44,963 | |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Sell | S | 11.02 | 3,037 | 33,479 | 2,799 | 5.8 K to 2.8 K (-52.04 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Buy | M | 1.75 | 3,037 | 5,315 | 5,836 | 2.8 K to 5.8 K (+108.50 %) |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 5.55 | 3,676 | 20,402 | 57,871 | |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 1.75 | 1,050 | 1,838 | 4,200 | |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 5.10 | 5,314 | 27,101 | 50,314 | |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 1.75 | 9,025 | 15,794 | 40,975 | |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Option Exercise | M | 3.53 | 23,206 | 81,801 | 0 | |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Sell | S | 10.14 | 42,271 | 428,717 | 7,735 | 50 K to 7.7 K (-84.53 %) |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 5.55 | 3,676 | 20,402 | 50,006 | 46.3 K to 50 K (+7.93 %) |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 1.75 | 1,050 | 1,838 | 46,330 | 45.3 K to 46.3 K (+2.32 %) |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 5.10 | 5,314 | 27,101 | 45,280 | 40 K to 45.3 K (+13.30 %) |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 1.75 | 9,025 | 15,794 | 39,966 | 30.9 K to 40 K (+29.17 %) |
Jul 29 2009 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | VP, Preclinical Res ... | Buy | M | 3.53 | 23,206 | 81,801 | 30,941 | 7.7 K to 30.9 K (+300.01 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 1.75 | 2,600 | 4,550 | 164,803 | |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Sell | S | 11.01 | 2,600 | 28,616 | 46,917 | 49.5 K to 46.9 K (-5.25 %) |
Jul 30 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 1.75 | 2,600 | 4,550 | 49,517 | 46.9 K to 49.5 K (+5.54 %) |
Jul 16 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.99 | 6,000 | 17,965 | 2,700,325 | 2.7 M to 2.7 M (+0.22 %) |
Jul 16 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.99 | 2,000 | 5,988 | 2,694,325 | 2.7 M to 2.7 M (+0.07 %) |
Jul 16 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.99 | 1,516 | 4,539 | 2,692,325 | 2.7 M to 2.7 M (+0.06 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.89 | 1,000 | 2,891 | 2,690,809 | 2.7 M to 2.7 M (+0.04 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.89 | 1,200 | 3,470 | 2,689,809 | 2.7 M to 2.7 M (+0.04 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.79 | 1,000 | 2,789 | 2,688,609 | 2.7 M to 2.7 M (+0.04 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.79 | 1,000 | 2,789 | 2,687,609 | 2.7 M to 2.7 M (+0.04 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.10 | 12,000 | 37,198 | 2,686,609 | 2.7 M to 2.7 M (+0.45 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.10 | 4,000 | 12,399 | 2,674,609 | 2.7 M to 2.7 M (+0.15 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.10 | 5,500 | 17,049 | 2,670,609 | 2.7 M to 2.7 M (+0.21 %) |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Option Exercise | A | 2.71 | 12,500 | 33,875 | 12,500 | |
Jun 18 2009 | CBIO | CATALYST BIOSCIENC ... | BARRETT M JAMES | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Jun 17 2009 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Option Exercise | A | 2.71 | 7,500 | 20,325 | 7,500 | |
Mar 18 2009 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Buy | P | 3.03 | 7,500 | 22,725 | 7,500 | 0 to 7.5 K |
Jan 13 2009 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | VP, Lg Affrs, GC an ... | Option Exercise | A | 2.93 | 46,000 | 134,780 | 46,000 | |
Jan 13 2009 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | A | 2.93 | 65,000 | 190,450 | 65,000 | |
Jan 13 2009 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | VP - Bus. & Commerc ... | Option Exercise | A | 2.93 | 52,500 | 153,825 | 52,500 | |
Jan 13 2009 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | VP, CFO & Treasurer | Option Exercise | A | 2.93 | 52,500 | 153,825 | 52,500 | |
Jan 13 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | A | 2.93 | 46,000 | 134,780 | 46,000 |